Refractory Nodal Peripheral T-Cell Lymphoma With TFH Phenotype
1 clinical trials · Condition
◉ Watch Refractory Nodal Peripheral T-Cell Lymphoma With TFH Phenotype
| Record | Firm | Date |
|---|---|---|
| Brentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell Lymphoma (NCT04795869) | Northwestern University | 2020-03-01 |
Track Refractory Nodal Peripheral T-Cell Lymphoma With TFH Phenotype automatically
Every clearance here is in the API, with alerts when new ones post.